Nosocomial outbreak by Proteus mirabilis producing extended-spectrum β-lactamase VEB-1 in a Korean university hospital

Journal of Antimicrobial Chemotherapy

Volumn 54, Issue 6, 2004, Pages 1144-1147

  Kim, Ja Young ^a   Park, Yeon Joon ^a   Kim, Sang Il ^a   Kang, Moon Won ^a   Lee, Seung Ok ^a   Lee, Kyo Young ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

lactam resistance; ESBLs; Multidrug resistant; P. mirabilis

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; BETA LACTAMASE VEB 1; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFUROXIME; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; PIPERACILLIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CONJUGATION; BACTERIUM ISOLATE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; ENTEROBACTERIACEAE; ENZYME ANALYSIS; ENZYME ASSAY; ENZYME INHIBITION; ENZYME SYNTHESIS; EPIDEMIC; GENE TRANSFER; GENETIC ANALYSIS; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; ISOELECTRIC FOCUSING; KOREA; MOLECULAR TYPING; NEUROENDOSCOPY; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEUS MIRABILIS; PULSED FIELD GEL ELECTROPHORESIS; SEQUENCE ANALYSIS; SPUTUM CULTURE; UNIVERSITY HOSPITAL; URINE CULTURE;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CROSS INFECTION; DISEASE OUTBREAKS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; HOSPITALS, UNIVERSITY; HUMANS; KOREA; PROTEUS INFECTIONS; PROTEUS MIRABILIS;

EID: 12344306260     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh486     Document Type: Article

References (10)

1. Luzzaro, F., Perilli, M., Amicosante, G. et al. (2001). Properties of multidrug-resistant, ESBL-producing Proteus mirabilis isolates and possible role of β-lactam/β -lactamase inhibitor combinations. International Journal of Antimicrobial Agents 17 131-5.
2. Naas, T., Benaoudia, F., Massuard, S. et al. (2000). Integron-located VEB-1 extended-spectrum β-lactamase gene in a Proteus mirabilis clinical isolate from Vietnam. Journal of Antimicrobial Chemotherapy 46, 703-11.
3. Poirel, L., Naas, T., Guibert, M. et al. (1999). Molecular and biochemical characterization of VEB-1, a novel class A extended-spectrum β-lactamase encoded by an Escherichia coli integron gene. Antimicrobial Agents and Chemotherapy 43, 573-81.
4. Girlich, D., Poirel, L., Leelaporn, A. et al. (2001). Molecular epidemiology of the integron-located VEB-1 extended-spectrum β-lactamase in nosocomial enterobacterial isolates in Bangkok, Thailand. Journal of Clinical Microbiology 39, 175-82.
5. Naas, T., Poirel, L., Karim, A. et al. (1999). Molecular characterization of In50, a class 1 integron encoding the gene for the extended-spectrum β-lactamase VEB-1 in Pseudomonas aeruginosa. FEMS Microbiology Letters 176, 411-9.
6. Poirel, L., Menuteau, O., Agoli, N. et al. (2003). Outbreak of extended-spectrum β-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital. Journal of Clinical Microbiology 41, 3542-7.
7. National Committee for Clinical Laboratory Standards. (2002). Performance Standards for Antimicrobial Disc Susceptibility Tests - Eighth Edition: Approved Standard M2-A8. NCCLS, Villanova, PA, USA.
8. Luzzaro, F., Mantengoli, E., Perilli, M. et al. (2002). Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum β-lactamase. Journal of Clinical Microbiology 39, 1865-70.
9. Poirel, L., Le Thomas, I., Naas, T. et al. (2000). Biochemical sequence analyses of GES-1, a novel class A extended-spectrum β-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy 44, 622-32.
10. Poirel, L., Rotimi, V. O., Mokaddas, E. M. et al. (2001). VEB-1-like extended-spectrum β-lactamases in Pseudomonas aeruginosa, Kuwait. Emerging Infectious Diseases 7, 468-70.